Oracle’s AI Cloud Wins With Governments And Healthcare Raise Valuation Questions
Oracle Corporation ORCL | 0.00 |
- Oracle (NYSE:ORCL) has secured major government and healthcare clients for its AI powered Fusion Cloud Applications.
- New deals include deployments across HR, finance, supply chain, and customer experience, fully integrated with AI.
- Clients span public sector agencies and leading institutions such as the Centre for Addiction and Mental Health (CAMH).
Oracle is drawing fresh attention as its AI infused cloud software gains ground with high profile public sector and healthcare customers, alongside its infrastructure footprint. The stock last closed at $192.64, with the share price down 9.1% over the past week and down 7.8% over the past year, after a multi year run that has seen it up 164.3% over five years. For investors tracking NYSE:ORCL, these contract wins indicate how the company is positioned across both large scale AI infrastructure and application level software.
These wins in government HR and healthcare operations highlight long duration, operational use of Oracle’s Fusion Cloud Applications in environments where reliability and compliance are central. For readers watching Oracle’s record backlog, capex, and financing headlines, this client traction in mission critical workflows provides another perspective on how demand for Oracle’s broader cloud applications ecosystem may evolve over time.
Stay updated on the most important news stories for Oracle by adding it to your watchlist or portfolio. Alternatively, explore our Community to discover new perspectives on Oracle.
Quick Assessment
- ✅ Price vs Analyst Target: At US$192.64, the stock trades about 24% below the US$252.64 analyst price target.
- ✅ Simply Wall St Valuation: Simply Wall St flags the shares as trading 59.5% below its estimated fair value.
- ⚖️ Recent Momentum: The 30 day return is slightly negative at 0.2%, suggesting the price has been broadly flat.
There's only one way to know the right time to buy, sell or hold Oracle. Head to Simply Wall St's company report for the latest analysis of Oracle's Fair Value.
Key Considerations
- 📊 Winning large public sector and healthcare clients for AI powered Fusion Cloud Applications reinforces Oracle’s role in long term, mission critical workloads.
- 📊 Watch how AI related application adoption, backlog trends, and any commentary on contract duration evolve in the context of the current P/E of 32.6x and industry P/E of 26.4x.
- ⚠️ Oracle carries a high level of debt and a high level of non cash earnings, so cash generation and balance sheet metrics remain important cross checks.
Dig Deeper
For the full picture including more risks and rewards, check out the complete Oracle analysis. Alternatively, you can check out the community page for Oracle to see how other investors believe this latest news will impact the company's narrative.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
